UNSPSC 51161567: Eprozinol dihydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C22H30N2O2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X9AMI360PI, chemically known as 1-piperazinepropanol, 4-(2-methoxy-2-phenylethyl)-.alpha.-phenyl-, hydrochloride (1:2), but more generally known as eprozinol dihydrochloride, which bears US NIH Compound Identifier 161574.

European Medicines Agency schedules eprozinol dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06589MIG. Most nations, for tariff purposes, schedule eprozinol dihydrochloride under HS 29335995. SMILES: COC(CN1CCN(CC1)CCC(C2CCCCC2)O)C3CCCCC3.CL.CL.

UNSPSC 51161567 Eprozinol dihydrochloride is a Commodity code covering a single pharmaceutical active ingredient with no recent state and local contract opportunities recorded in the source.

The code identifies a specific drug compound used in pharmaceutical manufacturing and formulation, but state and local procurement activity under this code does not appear in the available recent-opportunities data. Procurement professionals evaluating this code should verify current market demand through direct outreach to state health departments, Medicaid agencies, and institutional pharmacy networks, as the absence of recent solicitations may reflect either limited state and local use or procurement routed through federal purchasing vehicles, group purchasing organizations, or direct supplier relationships that do not generate public notices.